Tag: Bayer

Bayer’s annual general meeting on April 24 was a study in contradictions. Major institutional investors praised CEO Bill Anderson’s restructuring ...

Bayer enters a defining week with its stock under pressure, a Supreme Court hearing on the horizon, and shareholders having ...

Bayer is entering a defining period for its legal and financial future. The German life sciences group has secured preliminary ...

Bayer shareholders endured a rough session on Friday as the stock shed nearly 3% to close at €38.87, despite management's ...

Bayer enters one of its most consequential weeks in years, with a Supreme Court hearing on glyphosate liability looming just ...

Bayer shareholders have handed management a powerful financial weapon. At the company’s annual general meeting, they approved a blanket authorization ...

The contrast at Bayer has rarely been starker. At its Leverkusen headquarters, the company is celebrating a prestigious industry award ...

The coming days represent a defining moment for Bayer AG as two pivotal events converge, threatening to either cap a ...

The coming weeks will be critical for Bayer as two distinct but significant timelines—one legal, one financial—reach pivotal moments. While ...

April marks a critical juncture for Bayer, the Leverkusen-based life sciences conglomerate, as two major events converge. While the company's ...